Key Details
Price
$3.23Annual ROE
31.68%Beta
1.48Events Calendar
Next earnings date:
Mar 26, 2025Recent quarterly earnings:
Nov 05, 2024Recent annual earnings:
Mar 26, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Dec 30, 2005Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Paysign is a promising microcap payment processing company with a projected 42% annualized return, potentially reaching $19/share by 2030 from $3.30/share today. The company excels in two primary sectors: plasma payment processing and pharma patient affordability, both offering significant growth and high gross margins. PAYS's plasma business boasts a 40% market share with steady 10-15% annual growth, while the pharma segment is expected to surpass plasma with rapid expansion.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2024 Earnings Call.
Here is how Paysign, Inc. (PAYS) and Recruit Holdings Co., Ltd. (RCRRF) have performed compared to their sector so far this year.
Niche Focus: Paysign specializes in healthcare payment solutions, primarily in plasma donor compensation and patient affordability programs. Revenue Growth: Significant growth in the patient affordability segment is now a substantial part of total revenue. Financial Resilience: The company has shown strong revenue and margin recovery post-pandemic, with promising future growth.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their participation in the iAccess Alpha Buyside Best Ideas Summer Conference, June 25-26, 2024. Jeff Baker, Paysign's Chief Financial Officer, will deliver a presentation at 2:30 p.m. EDT on June 25, and is available to host one-on-one meetings the following day, Ju.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference.
PaySign continues to experience double-digit net sales growth driven by investments in prepaid card-based payment solutions for the plasma donation industry. The company has a strong presence with 465 plasma centers and 6.4 million cardholders, as well as sponsorship from large banks and card companies. The recent acquisition of shares by PaySign may lead to increased demand for the stock and lower cost of capital.
PaySign, Inc. (PAYS) Q4 2023 Earnings Call Transcript
PaySign, Inc. (NASDAQ:PAYS ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Mark Newcomer - Chief Executive Officer Jeff Baker - Chief Financial Officer Conference Call Participants Gary Prestopino - Barrington Research Operator Good afternoon. My name is Kevin, and I'll be your conference operator today.
FAQ
- What is the primary business of PaySign?
- What is the ticker symbol for PaySign?
- Does PaySign pay dividends?
- What sector is PaySign in?
- What industry is PaySign in?
- What country is PaySign based in?
- When did PaySign go public?
- Is PaySign in the S&P 500?
- Is PaySign in the NASDAQ 100?
- Is PaySign in the Dow Jones?
- When was PaySign's last earnings report?
- When does PaySign report earnings?
- Should I buy PaySign stock now?